BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 3723189)

  • 21. Iodine-131 MIBG for locating pheochromocytoma.
    Schober O; Gratz KF; Hundeshagen H
    J Nucl Med; 1986 Jul; 27(7):1222-3. PubMed ID: 3723197
    [No Abstract]   [Full Text] [Related]  

  • 22. Unusual causes of I-131 metaiodobenzylguanidine uptake in non-neural crest tissue.
    Horne T; Glaser B; Krausz Y; Rubinger D; Britton KE
    Clin Nucl Med; 1991 Apr; 16(4):239-42. PubMed ID: 2044316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nuclear medical therapy of pheochromocytoma].
    Fischer M; Winterberg B; Zidek W; Müller-Rensing R; Vetter H
    Schweiz Med Wochenschr; 1984 Dec; 114(49):1841-3. PubMed ID: 6515381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Detection of neural crest tumors by 123I-MIBG scintigraphy].
    Ikekubo K; Hino M; Ootsuka H; Ito H; Yamaguchi H; Dan Y; Masui Y; Bito S; Ohta K; Saiki Y
    Kaku Igaku; 1994 Nov; 31(11):1357-64. PubMed ID: 7837704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of scintigraphic imaging using 131iodine-metaiodobenzylguanidine in localization of asymptomatic pheochromocytoma.
    Yazaki T; Uchida K; Kaneko S; Tomomasa H; Ishikawa H; Kanoh S; Koiso K; Ishikawa N
    J Urol; 1985 Jul; 134(1):107-9. PubMed ID: 4009800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Nuclear medicine diagnosis of pheochromocytoma].
    Farahati J; Reiners C
    Zentralbl Chir; 1997; 122(6):443-6. PubMed ID: 9334110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [131-I-MIBG scintigraphy in the evaluation of suspected pheochromocytoma].
    Nakanishi F; Kasuga T; Sakai Y; Sone S; Watanabe T; Imai Y; Ito K; Yamashita K; Yano K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Dec; 47(12):1579-87. PubMed ID: 3452791
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma.
    Mangner TJ; Tobes MC; Wieland DW; Sisson JC; Shapiro B
    J Nucl Med; 1986 Jan; 27(1):37-44. PubMed ID: 3941363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic localization of extra-adrenal pheochromocytoma: comparison of (123)I-MIBG imaging and (131)I-MIBG imaging.
    Nakatani T; Hayama T; Uchida J; Nakamura K; Takemoto Y; Sugimura K
    Oncol Rep; 2002; 9(6):1225-7. PubMed ID: 12375024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A new medico-nuclear outlook for the diagnosis and treatment of pheochromocytomas: 131I-meta-iodobenzylguanidine (131I-MIBG). Comments on results obtained].
    Troncone L; Rufini V; Danza FM; Valenza V; Montemaggi P; Bonifazi N
    Radiol Med; 1986 Jun; 72(6):485-94. PubMed ID: 3715090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [131I-MIBG scintigraphy in diagnosing pheochromocytoma].
    Huang MJ; Tzen KY; Chen HY; Kao PF
    Taiwan Yi Xue Hui Za Zhi; 1987 Jul; 86(7):781-7. PubMed ID: 3681245
    [No Abstract]   [Full Text] [Related]  

  • 32. [131-iodine meta-iodobenzylguanidine scintigraphy and therapy in malignant pheochromocytoma].
    Kessel F; Hahn K; Eissner D; Beyer J; Thelen M
    Internist (Berl); 1986 Jan; 27(1):70-3. PubMed ID: 3514518
    [No Abstract]   [Full Text] [Related]  

  • 33. Rapid clearance of iodine-131 MIBG from the heart and liver of patients with adrenergic dysfunction and pheochromocytoma.
    Nakajo M; Shimabukuro K; Miyaji N; Shimada J; Shirono K; Sakata H; Yoshimura H; Yonekura R; Shinohara S
    J Nucl Med; 1985 Apr; 26(4):357-65. PubMed ID: 3981255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adrenomedullary scintigraphy with I-131 metaiodobenzylguanidine].
    Ohta Y; Takahashi E; Matsumoto Y; Kawasaki Y; Maki M; Hiroe D; Kusakabe K
    Rinsho Hoshasen; 1985 Mar; 30(3):399-400. PubMed ID: 4021133
    [No Abstract]   [Full Text] [Related]  

  • 35. Abnormal cardiac sympathetic nerve function in a patient with pheochromocytoma. An analysis using 123I metaiodobenzylguanidine scintigraphy.
    Izumi C; Himura Y; Konishi T
    Int J Cardiol; 1995 Jun; 50(2):189-92. PubMed ID: 7591331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant pheochromocytoma. Diffuse skeletal metastases manifested by I-123-metaiodobenzylguanidine scintigraphy.
    Shields AT; Sandler Ed; Parisi MT; Hattner RS
    Clin Nucl Med; 1993 Feb; 18(2):166-7. PubMed ID: 8432070
    [No Abstract]   [Full Text] [Related]  

  • 37. [123I-Metaiodobenzylguanidine- (MIBG-) scintigraphy: paradoxical positivity in an oncocytic adrenocortical carcinoma].
    Padberg BC; Rordorf T; Suter SL; Pfeiffer D; Wild D; Schröder S
    Pathologe; 2007 Jul; 28(4):281-4. PubMed ID: 16673076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitation of iodine-123 MIBG uptake by normal adrenal medulla in hypertensive patients.
    Bomanji J; Flatman WD; Horne T; Fettich J; Britton KE; Ross G; Besser GM
    J Nucl Med; 1987 Mar; 28(3):319-24. PubMed ID: 3819850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intraoperative localization of pheochromocytoma metastases using 131I-meta-benzylguanidine].
    Fasshauer H; Freundlieb O; Dostal G; Littmann K; Tharandt L; Strötges MW
    Nuklearmedizin; 1984 Aug; 23(4):203-5. PubMed ID: 6483632
    [No Abstract]   [Full Text] [Related]  

  • 40. Meta-iodobenzylguanidine in metastatic phaeochromocytoma.
    Stewart RJ; Anderson JR; Laird JD; Atkinson AB; Kennedy TL
    Clin Endocrinol (Oxf); 1984 Nov; 21(5):525-7. PubMed ID: 6499231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.